Verge Genomics Company
Verge Genomics uses machine learning and human genomics to accelerate drug discovery.
Investors
Connections from
Founded Date:
2015-01-01
Estimated Revenue:
$1M to $10M
Total Funding:
134120000
Investors Number:
26
Employee Number:
51-100
Last Funding Type:
Series B
Industry:
Neurodegeneration and aging
Headquarters:
San Francisco, California, United States
Funding Status:
Early Stage Venture
Last Funding Date:
2021-12-16